Ultrasound Therapy for Rheumatoid Arthritis
(At-home ULTRA Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new at-home ultrasound therapy for people with rheumatoid arthritis, a condition marked by painful, swollen joints. The researchers aim to determine if ultrasound waves can reduce inflammation by targeting the spleen, particularly in those unresponsive to other common treatments. Participants will be divided into groups: some will receive the active therapy, while others will receive a non-active version for comparison. The trial seeks individuals with moderate to severe rheumatoid arthritis who haven't found relief from usual treatments like methotrexate and similar medications. As an unphased trial, it offers a unique opportunity to explore innovative treatment options for those seeking alternatives.
Will I have to stop taking my current medications?
You can continue taking your current csDMARD medication, like methotrexate, as long as you've been on a stable dose for at least 8 weeks before the study and keep it stable during the study. If you've been on bDMARDs or tsDMARDs, you'll need to stop those at least 4 weeks before the study starts, and for Golimumab or Infliximab, at least 8 weeks before. You can also take up to 10 mg of prednisone daily if you've been on a stable dose for at least 6 weeks before the study.
What prior data suggests that this ultrasound therapy is safe for treating rheumatoid arthritis?
Research shows that ultrasound therapy devices, like the one tested in this trial, are generally safe. In a recent study, a similar ultrasound treatment proved safe and effective for reducing pain in arthritis patients. Participants using the ultrasound device experienced fewer side effects and tolerated the treatment well.
The at-home ultrasound device in this trial aims to reduce inflammation by sending sound waves to the spleen. This method is non-invasive, meaning it doesn't involve surgery or injections. Non-invasive treatments usually carry a lower risk of serious side effects compared to more invasive methods.
While specific details on side effects for this trial's device are not yet available, the technology has been used safely in other situations. This provides some confidence in its safety for participants. However, since this is a clinical trial, medical experts closely monitor all potential risks. Participants will be informed of any known risks before deciding to join.12345Why are researchers excited about this trial?
Researchers are excited about this ultrasound therapy for rheumatoid arthritis because it offers a new, noninvasive approach to managing the condition. Unlike traditional treatments like NSAIDs, DMARDs, or biologics, which often involve systemic medication, this therapy targets the spleen directly with localized ultrasound waves. This novel delivery method might reduce inflammation without the side effects associated with oral or injectable medications. Plus, the convenience of at-home treatment could greatly enhance patient adherence and quality of life.
What evidence suggests that this trial's ultrasound therapy treatments could be effective for rheumatoid arthritis?
This trial will compare different ultrasound therapy settings for rheumatoid arthritis. Research has shown that ultrasound therapy might help reduce inflammation, a major issue in rheumatoid arthritis. The therapy uses ultrasound waves to target the spleen, encouraging it to produce substances that fight inflammation. Participants in this trial may receive daily noninvasive ultrasound stimulation using either Treatment Setting 1 or Treatment Setting 2. Early results suggest this treatment could benefit those who haven't found relief with standard medications. Although more studies are needed, this method appears promising for individuals with moderate to severe rheumatoid arthritis.12346
Who Is on the Research Team?
Daniel Zachs
Principal Investigator
SecondWave Systems Inc.
Are You a Good Fit for This Trial?
Adults with active, moderate to severe rheumatoid arthritis who haven't had success with or can't tolerate standard treatments like csDMARDs, bDMARDs, or tsDMARDs. At least 60 participants will be recruited across up to 8 sites.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive daily noninvasive ultrasound stimulation of the spleen for 20 minutes once per day
Crossover
Control participants crossover to active stimulation
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- At-home Ultrasound Localized Therapy
Trial Overview
The trial is testing the MINI system's ability to deliver non-invasive ultrasound stimulation to the spleen as a treatment for reducing inflammation in rheumatoid arthritis patients. It includes two different settings of active treatment and one sham (fake) control group.
How Is the Trial Designed?
3
Treatment groups
Experimental Treatment
Placebo Group
Subjects will receive daily noninvasive ultrasound stimulation of the spleen using Ultrasound Treatment Setting 2 for 20 minutes once per day
Subjects will receive daily noninvasive ultrasound stimulation of the spleen using Ultrasound Treatment Setting 1 for 20 minutes once per day
Non-active Sham Stimulation
Find a Clinic Near You
Who Is Running the Clinical Trial?
SecondWave Systems Inc.
Lead Sponsor
Citations
Study Details | NCT07163221 | At-home Ultrasound ...
The At-Home ULTRA Study will evaluate performance of the MINI system as indicated for the treatment of adults with active, ...
At-home Ultrasound Localized Therapy for Rheumatoid ...
Overview. The At-Home ULTRA Study will evaluate performance of the MINI system as indicated for the treatment of adults with active, ...
Practical Use of Ultrasound in Modern Rheumatology—From ...
The US is currently used as the imaging method of choice for establishing an early diagnosis, assessing disease activity, monitoring treatment efficacy.
4.
trial.medpath.com
trial.medpath.com/clinical-trial/f414e5eea4f06a11/nct07163221-at-home-ultrasound-therapy-rheumatoid-arthritisAt-home Ultrasound Localized Therapy for Rheumatoid ...
The At-Home ULTRA Study will evaluate performance of the MINI system as indicated for the treatment of adults with active, moderate to severe rheumatoid ...
Clinical and Ultrasonographic Remission in Bio-naïve and ...
Here we present the 24-week data of the UPAdacitinib Rheumatoid Arthritis REmission UltraSonography (UPARAREMUS) study, a multicenter ...
Arthritis
A recent clinical trial was completed in Japan and revealed that MRgFUS ablation was both safe and effective at treating chronic pain caused by ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.